Cargando…

Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration

PURPOSE: To probabilistically forecast needed anti-vascular endothelial growth factor (anti-VEGF) treatment frequency using volumetric spectral domain–optical coherence tomography (SD-OCT) biomarkers in neovascular age-related macular degeneration from real-world settings. METHODS: SD-OCT volume sca...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfau, Maximilian, Sahu, Soumya, Rupnow, Rawan Allozi, Romond, Kathleen, Millet, Desiree, Holz, Frank G., Schmitz-Valckenberg, Steffen, Fleckenstein, Monika, Lim, Jennifer I., de Sisternes, Luis, Leng, Theodore, Rubin, Daniel L., Hallak, Joelle A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254013/
https://www.ncbi.nlm.nih.gov/pubmed/34185055
http://dx.doi.org/10.1167/tvst.10.7.30
_version_ 1783717638503923712
author Pfau, Maximilian
Sahu, Soumya
Rupnow, Rawan Allozi
Romond, Kathleen
Millet, Desiree
Holz, Frank G.
Schmitz-Valckenberg, Steffen
Fleckenstein, Monika
Lim, Jennifer I.
de Sisternes, Luis
Leng, Theodore
Rubin, Daniel L.
Hallak, Joelle A.
author_facet Pfau, Maximilian
Sahu, Soumya
Rupnow, Rawan Allozi
Romond, Kathleen
Millet, Desiree
Holz, Frank G.
Schmitz-Valckenberg, Steffen
Fleckenstein, Monika
Lim, Jennifer I.
de Sisternes, Luis
Leng, Theodore
Rubin, Daniel L.
Hallak, Joelle A.
author_sort Pfau, Maximilian
collection PubMed
description PURPOSE: To probabilistically forecast needed anti-vascular endothelial growth factor (anti-VEGF) treatment frequency using volumetric spectral domain–optical coherence tomography (SD-OCT) biomarkers in neovascular age-related macular degeneration from real-world settings. METHODS: SD-OCT volume scans were segmented with a custom deep-learning-based analysis pipeline. Retinal thickness and reflectivity values were extracted for the central and the four inner Early Treatment Diabetic Retinopathy Study (ETDRS) subfields for six retinal layers (inner retina, outer nuclear layer, inner segments [IS], outer segments [OS], retinal pigment epithelium-drusen complex [RPEDC] and the choroid). Machine-learning models were probed to predict the anti-VEGF treatment frequency within the next 12 months. Probabilistic forecasting was performed using natural gradient boosting (NGBoost), which outputs a full probability distribution. The mean absolute error (MAE) between the predicted versus actual anti-VEGF treatment frequency was the primary outcome measure. RESULTS: In a total of 138 visits of 99 eyes with neovascular AMD (96 patients) from two clinical centers, the prediction of future anti-VEGF treatment frequency was observed with an accuracy (MAE [95% confidence interval]) of 2.60 injections/year [2.25–2.96] (R(2) = 0.390) using random forest regression and 2.66 injections/year [2.31–3.01] (R(2) = 0.094) using NGBoost, respectively. Prediction intervals were well calibrated and reflected the true uncertainty of NGBoost-based predictions. Standard deviation of RPEDC-thickness in the central ETDRS-subfield constituted an important predictor across models. CONCLUSIONS: The proposed, fully automated pipeline enables probabilistic forecasting of future anti-VEGF treatment frequency in real-world settings. TRANSLATIONAL RELEVANCE: Prediction of a probability distribution allows the physician to inspect the underlying uncertainty. Predictive uncertainty estimates are essential to highlight cases where human-inspection and/or reversion to a fallback alternative is warranted.
format Online
Article
Text
id pubmed-8254013
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Association for Research in Vision and Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-82540132021-07-08 Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration Pfau, Maximilian Sahu, Soumya Rupnow, Rawan Allozi Romond, Kathleen Millet, Desiree Holz, Frank G. Schmitz-Valckenberg, Steffen Fleckenstein, Monika Lim, Jennifer I. de Sisternes, Luis Leng, Theodore Rubin, Daniel L. Hallak, Joelle A. Transl Vis Sci Technol Article PURPOSE: To probabilistically forecast needed anti-vascular endothelial growth factor (anti-VEGF) treatment frequency using volumetric spectral domain–optical coherence tomography (SD-OCT) biomarkers in neovascular age-related macular degeneration from real-world settings. METHODS: SD-OCT volume scans were segmented with a custom deep-learning-based analysis pipeline. Retinal thickness and reflectivity values were extracted for the central and the four inner Early Treatment Diabetic Retinopathy Study (ETDRS) subfields for six retinal layers (inner retina, outer nuclear layer, inner segments [IS], outer segments [OS], retinal pigment epithelium-drusen complex [RPEDC] and the choroid). Machine-learning models were probed to predict the anti-VEGF treatment frequency within the next 12 months. Probabilistic forecasting was performed using natural gradient boosting (NGBoost), which outputs a full probability distribution. The mean absolute error (MAE) between the predicted versus actual anti-VEGF treatment frequency was the primary outcome measure. RESULTS: In a total of 138 visits of 99 eyes with neovascular AMD (96 patients) from two clinical centers, the prediction of future anti-VEGF treatment frequency was observed with an accuracy (MAE [95% confidence interval]) of 2.60 injections/year [2.25–2.96] (R(2) = 0.390) using random forest regression and 2.66 injections/year [2.31–3.01] (R(2) = 0.094) using NGBoost, respectively. Prediction intervals were well calibrated and reflected the true uncertainty of NGBoost-based predictions. Standard deviation of RPEDC-thickness in the central ETDRS-subfield constituted an important predictor across models. CONCLUSIONS: The proposed, fully automated pipeline enables probabilistic forecasting of future anti-VEGF treatment frequency in real-world settings. TRANSLATIONAL RELEVANCE: Prediction of a probability distribution allows the physician to inspect the underlying uncertainty. Predictive uncertainty estimates are essential to highlight cases where human-inspection and/or reversion to a fallback alternative is warranted. The Association for Research in Vision and Ophthalmology 2021-06-29 /pmc/articles/PMC8254013/ /pubmed/34185055 http://dx.doi.org/10.1167/tvst.10.7.30 Text en Copyright 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
spellingShingle Article
Pfau, Maximilian
Sahu, Soumya
Rupnow, Rawan Allozi
Romond, Kathleen
Millet, Desiree
Holz, Frank G.
Schmitz-Valckenberg, Steffen
Fleckenstein, Monika
Lim, Jennifer I.
de Sisternes, Luis
Leng, Theodore
Rubin, Daniel L.
Hallak, Joelle A.
Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration
title Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration
title_full Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration
title_fullStr Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration
title_full_unstemmed Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration
title_short Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration
title_sort probabilistic forecasting of anti-vegf treatment frequency in neovascular age-related macular degeneration
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254013/
https://www.ncbi.nlm.nih.gov/pubmed/34185055
http://dx.doi.org/10.1167/tvst.10.7.30
work_keys_str_mv AT pfaumaximilian probabilisticforecastingofantivegftreatmentfrequencyinneovascularagerelatedmaculardegeneration
AT sahusoumya probabilisticforecastingofantivegftreatmentfrequencyinneovascularagerelatedmaculardegeneration
AT rupnowrawanallozi probabilisticforecastingofantivegftreatmentfrequencyinneovascularagerelatedmaculardegeneration
AT romondkathleen probabilisticforecastingofantivegftreatmentfrequencyinneovascularagerelatedmaculardegeneration
AT milletdesiree probabilisticforecastingofantivegftreatmentfrequencyinneovascularagerelatedmaculardegeneration
AT holzfrankg probabilisticforecastingofantivegftreatmentfrequencyinneovascularagerelatedmaculardegeneration
AT schmitzvalckenbergsteffen probabilisticforecastingofantivegftreatmentfrequencyinneovascularagerelatedmaculardegeneration
AT fleckensteinmonika probabilisticforecastingofantivegftreatmentfrequencyinneovascularagerelatedmaculardegeneration
AT limjenniferi probabilisticforecastingofantivegftreatmentfrequencyinneovascularagerelatedmaculardegeneration
AT desisternesluis probabilisticforecastingofantivegftreatmentfrequencyinneovascularagerelatedmaculardegeneration
AT lengtheodore probabilisticforecastingofantivegftreatmentfrequencyinneovascularagerelatedmaculardegeneration
AT rubindaniell probabilisticforecastingofantivegftreatmentfrequencyinneovascularagerelatedmaculardegeneration
AT hallakjoellea probabilisticforecastingofantivegftreatmentfrequencyinneovascularagerelatedmaculardegeneration